Iain Miller's Biography

Iain Miller, Co-Founder, Healthcare Strategies Group

Iain Miller is Founder of Healthcare Strategies Group, which focuses on providing commercial strategy advisory services for the diagnostic, pharmaceutical and life science tools sectors. In this capacity, he is an active contributor to several international policy initiatives, including The European PErsonalised MEDicine association (EPEMED), where he has served as a founding board member since its inception in 2009. Iain is also a member of Technology Appraisal Committee C of NICE, which reviews submissions for new drugs and companion tests for use in the UK NHS, and sits on the MedTech Advisory Board of Oxford Bioscience Network . He is a healthcare strategy and commercial development executive with over 20 years of diverse healthcare technology experience gained in a variety of settings and geographies primarily in the US. Prior to Healthcare Strategies Group, he was with GE Healthcare, where he served as Global Head, Personalized Healthcare Strategy & Partnerships. Previously, at bioMerieux, Iain was responsible for oncology strategy and also led strategy and business development for the Personalized Medicine Business Unit. His experience base also includes founding of two medical technology startups, leadership roles in two venture-backed genomics companies, and a technology transfer executive role at Massachusetts General Hospital in Boston. Iain holds a Ph.D. in Biomedical Engineering from the University of Strathclyde, an MBA from Edinburgh Business School and a bachelors degree in Physics from the University of Glasgow. Iain’s recent publications include a paper in a 2014 issue of Current Pharmacogenomics and Personalized Medicine titled “Best Practices and Emerging Trends for Market Access to Personalised Medicine in the US and EU: Learnings for Global Developed and Emerging Markets”, and Steering Committee membership of the UK Academy of Medical Sciences Stratified Medicine market access report, which published in 2013.